These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


341 related items for PubMed ID: 8976111

  • 1. [PRPP synthetase superactivity].
    Fujimori S.
    Nihon Rinsho; 1996 Dec; 54(12):3309-14. PubMed ID: 8976111
    [Abstract] [Full Text] [Related]

  • 2. Mutant feedback-resistant phosphoribosylpyrophosphate synthetase associated with purine overproduction and gout. Phosphoribosylpyrophosphate and purine metabolism in cultured fibroblasts.
    Zoref E, De Vries A, Sperling O.
    J Clin Invest; 1975 Nov; 56(5):1093-9. PubMed ID: 171280
    [Abstract] [Full Text] [Related]

  • 3. Gout with superactive phosphoribosylpyrophosphate synthetase due to increased enzyme catalytic rate.
    Becker MA, Losman MJ, Itkin P, Simkin PA.
    J Lab Clin Med; 1982 Apr; 99(4):495-511. PubMed ID: 6174658
    [Abstract] [Full Text] [Related]

  • 4. [Increased activity of PRPP synthetase].
    Iizasa T.
    Nihon Rinsho; 2008 Apr; 66(4):694-8. PubMed ID: 18409517
    [Abstract] [Full Text] [Related]

  • 5. [PRPP synthetase superactivity].
    Kawasugi K, Takeuchi F.
    Nihon Rinsho; 2003 Jan; 61 Suppl 1():284-7. PubMed ID: 12629732
    [No Abstract] [Full Text] [Related]

  • 6. [Mammalian phosphoribosylpyrophosphate synthetase].
    Tatibana M.
    Nihon Rinsho; 1996 Dec; 54(12):3195-201. PubMed ID: 8976091
    [Abstract] [Full Text] [Related]

  • 7. Phosphoribosylpyrophosphate synthetase overactivity as a cause of uric acid overproduction in a young woman.
    García-Pavía P, Torres RJ, Rivero M, Ahmed M, García-Puig J, Becker MA.
    Arthritis Rheum; 2003 Jul; 48(7):2036-41. PubMed ID: 12847698
    [Abstract] [Full Text] [Related]

  • 8. A novel mutation in gene of PRPS1 in a young Chinese woman with X-linked gout: a case report and review of the literature.
    Yang BY, Yu HX, Min J, Song XX.
    Clin Rheumatol; 2020 Mar; 39(3):949-956. PubMed ID: 31773495
    [Abstract] [Full Text] [Related]

  • 9. Neurodevelopmental impairment and deranged PRPP and purine nucleotide synthesis in inherited superactivity of PRPP synthetase.
    Becker MA, Puig JG, Mateos FA, Jimenez ML, Kim M, Simmonds HA.
    Adv Exp Med Biol; 1989 Mar; 253A():15-22. PubMed ID: 2483028
    [No Abstract] [Full Text] [Related]

  • 10. The genetic and functional basis of purine nucleotide feedback-resistant phosphoribosylpyrophosphate synthetase superactivity.
    Becker MA, Smith PR, Taylor W, Mustafi R, Switzer RL.
    J Clin Invest; 1995 Nov; 96(5):2133-41. PubMed ID: 7593598
    [Abstract] [Full Text] [Related]

  • 11. Accelerated transcription of PRPS1 in X-linked overactivity of normal human phosphoribosylpyrophosphate synthetase.
    Ahmed M, Taylor W, Smith PR, Becker MA.
    J Biol Chem; 1999 Mar 12; 274(11):7482-8. PubMed ID: 10066814
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Inherited superactivity of phosphoribosylpyrophosphate synthetase: association of uric acid overproduction and sensorineural deafness.
    Becker MA, Puig JG, Mateos FA, Jimenez ML, Kim M, Simmonds HA.
    Am J Med; 1988 Sep 12; 85(3):383-90. PubMed ID: 2843048
    [Abstract] [Full Text] [Related]

  • 16. Patterns of phosphoribosylpyrophosphate and ribose-5-phosphate concentration and generation in fibroblasts from patients with gout and purine overproduction.
    Becker MA.
    J Clin Invest; 1976 Feb 12; 57(2):308-18. PubMed ID: 176178
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 18.